Failure of Alzheimer’s Disease Study Creates a New Penny Stock

(Bloomberg) -- Neurotrope Inc. plunged as much as 82%, falling below a dollar, after a placebo worked better than the company’s experimental treatment for Alzheimer’s disease.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.